These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 21315588
1. Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitors. Shen HC, Ding FX, Zhou C, Xiong Y, Verras A, Chabin RM, Xu S, Tong X, Xie D, Lassman ME, Bhatt UR, Garcia-Calvo MM, Geissler W, Shen Z, Chen D, Sinharoy R, Hale JJ, Tata JR, Pinto S, Shen DM, Colletti SL. Bioorg Med Chem Lett; 2011 Mar 01; 21(5):1299-305. PubMed ID: 21315588 [Abstract] [Full Text] [Related]
2. The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors. Graham TH, Shen HC, Liu W, Xiong Y, Verras A, Bleasby K, Bhatt UR, Chabin RM, Chen D, Chen Q, Garcia-Calvo M, Geissler WM, He H, Lassman ME, Shen Z, Tong X, Tung EC, Xie D, Xu S, Colletti SL, Tata JR, Hale JJ, Pinto S, Shen DM. Bioorg Med Chem Lett; 2012 Jan 01; 22(1):658-65. PubMed ID: 22079761 [Abstract] [Full Text] [Related]
3. A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation. Graham TH, Liu W, Verras A, Sebhat IK, Xiong Y, Bleasby K, Bhatt UR, Chen Q, Garcia-Calvo M, Geissler WM, Gorski JN, He H, Lassman ME, Lisnock J, Li X, Shen Z, Tong X, Tung EC, Wiltsie J, Xiao J, Xie D, Xu S, Hale JJ, Pinto S, Shen DM. Bioorg Med Chem Lett; 2012 Apr 15; 22(8):2811-7. PubMed ID: 22444683 [Abstract] [Full Text] [Related]
4. Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitors. Shen HC, Ding FX, Jiang J, Verras A, Chabin RM, Xu S, Tong X, Chen Q, Xie D, Lassman ME, Bhatt UR, Garcia-Calvo MM, Geissler W, Shen Z, Murphy BA, Gorski JN, Wiltsie J, SinhaRoy R, Hale JJ, Pinto S, Shen DM. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1550-6. PubMed ID: 22264488 [Abstract] [Full Text] [Related]
5. Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors. Wu Z, Yang C, Graham TH, Verras A, Chabin RM, Xu S, Tong X, Xie D, Lassman ME, Bhatt UR, Garcia-Calvo MM, Shen Z, Chen Q, Bleasby K, Sinharoy R, Hale JJ, Tata JR, Pinto S, Colletti SL, Shen DM. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1727-30. PubMed ID: 22290078 [Abstract] [Full Text] [Related]
6. A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes. Graham TH, Liu W, Verras A, Reibarkh M, Bleasby K, Bhatt UR, Chen Q, Garcia-Calvo M, Geissler WM, Gorski JN, He H, Lassman ME, Lisnock J, Li X, Shen Z, Tong X, Tung EC, Wiltsie J, Xie D, Xu S, Xiao J, Hale JJ, Pinto S, Shen DM. Bioorg Med Chem Lett; 2012 Apr 15; 22(8):2818-22. PubMed ID: 22444685 [Abstract] [Full Text] [Related]
7. Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanine. Wu Z, Yang C, Xiong Y, Feng Z, Lombardo M, Verras A, Chabin RM, Xu S, Tong X, Xie D, Lassman ME, Bhatt UR, Garcia-Calvo MM, Geissler W, Shen Z, Chen Q, Sinharoy R, Hale JJ, Tata JR, Pinto S, Shen DM, Colletti SL. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1774-8. PubMed ID: 22248857 [Abstract] [Full Text] [Related]
8. Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors. Debenham JS, Graham TH, Verras A, Zhang Y, Clements MJ, Kuethe JT, Madsen-Duggan C, Liu W, Bhatt UR, Chen D, Chen Q, Garcia-Calvo M, Geissler WM, He H, Li X, Lisnock J, Shen Z, Tong X, Tung EC, Wiltsie J, Xu S, Hale JJ, Pinto S, Shen DM. Bioorg Med Chem Lett; 2013 Dec 01; 23(23):6228-33. PubMed ID: 24157366 [Abstract] [Full Text] [Related]
9. Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity. Zhou C, Garcia-Calvo M, Pinto S, Lombardo M, Feng Z, Bender K, Pryor KD, Bhatt UR, Chabin RM, Geissler WM, Shen Z, Tong X, Zhang Z, Wong KK, Roy RS, Chapman KT, Yang L, Xiong Y. J Med Chem; 2010 Oct 14; 53(19):7251-63. PubMed ID: 20857914 [Abstract] [Full Text] [Related]
10. Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk). Moriarty KJ, Takahashi H, Pullen SS, Khine HH, Sallati RH, Raymond EL, Woska JR, Jeanfavre DD, Roth GP, Winters MP, Qiao L, Ryan D, DesJarlais R, Robinson D, Wilson M, Bobko M, Cook BN, Lo HY, Nemoto PA, Kashem MA, Wolak JP, White A, Magolda RL, Tomczuk B. Bioorg Med Chem Lett; 2008 Oct 15; 18(20):5545-9. PubMed ID: 18819799 [Abstract] [Full Text] [Related]
11. Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors. Lee K, Goo JI, Jung HY, Kim M, Boovanahalli SK, Park HR, Kim MO, Kim DH, Lee HS, Choi Y. Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7456-60. PubMed ID: 23141914 [Abstract] [Full Text] [Related]
12. Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors. Graham TH, Shu M, Verras A, Chen Q, Garcia-Calvo M, Li X, Lisnock J, Tong X, Tung EC, Wiltsie J, Hale JJ, Pinto S, Shen DM. Bioorg Med Chem Lett; 2014 Apr 01; 24(7):1657-60. PubMed ID: 24636945 [Abstract] [Full Text] [Related]
13. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I. Roche D, Carniato D, Leriche C, Lepifre F, Christmann-Franck S, Graedler U, Charon C, Bozec S, Doare L, Schmidlin F, Lecomte M, Valeur E. Bioorg Med Chem Lett; 2009 May 15; 19(10):2674-8. PubMed ID: 19395260 [Abstract] [Full Text] [Related]
14. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics. Dang Q, Kasibhatla SR, Xiao W, Liu Y, Dare J, Taplin F, Reddy KR, Scarlato GR, Gibson T, van Poelje PD, Potter SC, Erion MD. J Med Chem; 2010 Jan 14; 53(1):441-51. PubMed ID: 20055427 [Abstract] [Full Text] [Related]
15. The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors. Cheng H, Hoffman J, Le P, Nair SK, Cripps S, Matthews J, Smith C, Yang M, Kupchinsky S, Dress K, Edwards M, Cole B, Walters E, Loh C, Ermolieff J, Fanjul A, Bhat GB, Herrera J, Pauly T, Hosea N, Paderes G, Rejto P. Bioorg Med Chem Lett; 2010 May 01; 20(9):2897-902. PubMed ID: 20363126 [Abstract] [Full Text] [Related]
16. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. Borza I, Kolok S, Gere A, Nagy J, Fodor L, Galgóczy K, Fetter J, Bertha F, Agai B, Horváth C, Farkas S, Domány G. Bioorg Med Chem Lett; 2006 Sep 01; 16(17):4638-40. PubMed ID: 16782335 [Abstract] [Full Text] [Related]
17. Discovery of triazine-benzimidazoles as selective inhibitors of mTOR. Peterson EA, Andrews PS, Be X, Boezio AA, Bush TL, Cheng AC, Coats JR, Colletti AE, Copeland KW, DuPont M, Graceffa R, Grubinska B, Harmange JC, Kim JL, Mullady EL, Olivieri P, Schenkel LB, Stanton MK, Teffera Y, Whittington DA, Cai T, La DS. Bioorg Med Chem Lett; 2011 Apr 01; 21(7):2064-70. PubMed ID: 21376583 [Abstract] [Full Text] [Related]
18. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors. Webster SP, Ward P, Binnie M, Craigie E, McConnell KM, Sooy K, Vinter A, Seckl JR, Walker BR. Bioorg Med Chem Lett; 2007 May 15; 17(10):2838-43. PubMed ID: 17350260 [Abstract] [Full Text] [Related]
19. N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors. Nepali K, Agarwal A, Sapra S, Mittal V, Kumar R, Banerjee UC, Gupta MK, Satti NK, Suri OP, Dhar KL. Bioorg Med Chem; 2011 Sep 15; 19(18):5569-76. PubMed ID: 21862335 [Abstract] [Full Text] [Related]
20. New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors. Hulin B, Cabral S, Lopaze MG, Van Volkenburg MA, Andrews KM, Parker JC. Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4770-3. PubMed ID: 16115768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]